BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25031326)

  • 1. New targets for atherothrombosis.
    Mackman N
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1607-8. PubMed ID: 25031326
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
    Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
    van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors IX, XI, and XII: potential therapeutic targets for anticoagulant therapy in atherothrombosis.
    Rai V; Balters MW; Agrawal DK
    Rev Cardiovasc Med; 2019 Dec; 20(4):245-253. PubMed ID: 31912715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.
    Walsh PN; Griffin JH
    Blood; 1981 Jan; 57(1):106-18. PubMed ID: 7004531
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor XI and XII as antithrombotic targets.
    Müller F; Gailani D; Renné T
    Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet coagulant activities: evidence for multiple different functions of platelets in intrinsic coagulation.
    Walsh PN
    Ser Haematol; 1973; 6(4):579-92. PubMed ID: 4795011
    [No Abstract]   [Full Text] [Related]  

  • 8. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).
    Wiggins RC; Cochrane CG; Griffin JH
    Thromb Res; 1979; 15(3-4):487-95. PubMed ID: 494157
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 10. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.
    Bouma BN; Griffin JH
    J Biol Chem; 1977 Sep; 252(18):6432-7. PubMed ID: 893417
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor XI and factor XII as targets for new anticoagulants.
    Weitz JI
    Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulant therapy in cardiovascular diseases. I. Thrombus formation and anticoagulants].
    Latallo ZS; Malanowicz W
    Kardiol Pol; 1970; 13(4):351-8. PubMed ID: 4099312
    [No Abstract]   [Full Text] [Related]  

  • 13. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
    Murano G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585
    [No Abstract]   [Full Text] [Related]  

  • 14. Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.
    Spronk HMH; Padro T; Siland JE; Prochaska JH; Winters J; van der Wal AC; Posthuma JJ; Lowe G; d'Alessandro E; Wenzel P; Coenen DM; Reitsma PH; Ruf W; van Gorp RH; Koenen RR; Vajen T; Alshaikh NA; Wolberg AS; Macrae FL; Asquith N; Heemskerk J; Heinzmann A; Moorlag M; Mackman N; van der Meijden P; Meijers JCM; Heestermans M; Renné T; Dólleman S; Chayouâ W; Ariëns RAS; Baaten CC; Nagy M; Kuliopulos A; Posma JJ; Harrison P; Vries MJ; Crijns HJGM; Dudink EAMP; Buller HR; Henskens YMC; Själander A; Zwaveling S; Erküner O; Eikelboom JW; Gulpen A; Peeters FECM; Douxfils J; Olie RH; Baglin T; Leader A; Schotten U; Scaf B; van Beusekom HMM; Mosnier LO; van der Vorm L; Declerck P; Visser M; Dippel DWJ; Strijbis VJ; Pertiwi K; Ten Cate-Hoek AJ; Ten Cate H
    Thromb Haemost; 2018 Feb; 118(2):229-250. PubMed ID: 29378352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic and clinical data linking factors XI and XII to thrombosis.
    Key NS
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):66-70. PubMed ID: 25696836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of surfaces in contact phase reactions.
    Vroman L
    Semin Thromb Hemost; 1987 Jan; 13(1):79-85. PubMed ID: 3551077
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet interaction with the contact system of coagulation.
    Scully MF; Weersinghe KM; Kakkar VV
    Adv Exp Med Biol; 1985; 192():389-98. PubMed ID: 3914835
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of surface-sensitive coagulation factors XII and XI in intravasal coagulation].
    Müller-Berghaus G; Ehlers E; Käufer P
    Verh Dtsch Ges Inn Med; 1974; 80():1458-60. PubMed ID: 4454455
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of thorium dioxide upon blood clotting and platelets. I. In vitro studies.
    Hjort PF; McGehee WG; Rapaport SI
    Thromb Diath Haemorrh; 1966 Dec; 16(3):333-53. PubMed ID: 5996663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.